Navigation Links
Veterinary researchers study poultry virus as human cancer treatment
Date:2/12/2008

According to Subbiah, the use of poultry viruses as cancer therapy poses no threat to humans and several other oncolytic viruses are currently being explored to treat cancer. However, Subbiahs work is the first to alter the Newcastle disease virus through a reverse genetic system for selective protease targeting. Oncolytic virus therapy has gained much attention recently as a result of the progress in understanding virus-host interactions and because currently available chemotherapy is not entirely satisfactory for several reasons, including the possibility of an individuals development of resistance to drugs.

We are excited about the endless possibilities that Newcastle disease virus offers to treat cancer, said Subbiah.

This is the second major grant awarded to the researchers for the work aiming to create a cancer therapy from genetically altered Newcastle Disease virus.

Subbiah received his bachelors degree in veterinary science in 1984, masters degree in veterinary science in 1989, and Ph.D. in veterinary microbiology in 1996 from the Madras Veterinary College in Madras, India; and he was boarded in virology from the American College of Veterinary Microbiologists in 2003. He was a research assistant professor at the Virginia-Maryland Regional College of Veterinary Medicines College Park, Md., campus prior to joining Virginia Tech in 2006.

Samal received his bachelors degree in veterinary science from Orissa Veterinary College (India) in 1976, his masters degree in veterinary science from the Indian Veterinary Research Institute, and master of science and Ph.D. degrees from Texas A&M University. He joined the faculty at the University of Maryland in 1988, and is currently the associate dean of the Virginia-Maryland Regional College of Veterinary Medicine and chair of the Department of Veterinary Medicine at the University of Maryland in College Park.


'/>"/>

Contact: Christy Jackson
cljacks@vt.edu
540-231-7239
Virginia Tech
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine
2. Veterinary Pet Insurance Data Reveals Pet Dental Health a Low Priority for Many Pet Owners
3. New Company Enters Companion Animal Veterinary Medicine Channel
4. Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to January 4, 2008
5. Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to December 28, 2007
6. AVMA Lauds Senators for Approving 2007 Farm Bill Legislation that Includes the Veterinary Workforce Grant Program
7. Veterinary Dentistry Opens Wide
8. Echo Healthcare Reschedules Stockholder Vote on Proposed Merger With XLNT Veterinary Care to December 21, 2007
9. BCP Veterinary Pharmacy Helps Cure Diabetic Cats with BCP PZI(R), the Closest Match to Feline Insulin Available
10. California Veterinary Medical Association Reacts to Supreme Court Decision
11. Henricksen Awarded 2007 Distinguished Veterinary Staff Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... Follow us on LinkedIn – Breast ... from the breast of a lactating mother through the suction ... feeding the baby. Breast pumps are used when direct feeding ... the mother being away from a child for a longer ... pumps are also used to stimulate lactation and relieve engorgement ...
(Date:3/4/2015)... 2015 Brassica Protection Products LLC, an ... rebrand of its SGS™ brand of glucoraphanin to truebroc™. ... glucoraphanin, which is the most concentrated source of glucoraphanin ... includes a new truebroc logo and refreshed website and ... brand name. , “We are thrilled to unveil ...
(Date:3/4/2015)... Whatever one's feelings about the Fifty Shades of Grey™ phenomenon, ... hard-core fans of the trilogy, to people in the BDSM ... even one of the books, is putting their two cents ... manager of HUSH, a leading retailer of adult sexual health ... thing. , "When the books came out in 2011 we ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 The defibrillators ... defibrillators market. According to the report the global market ... from 2014 to reach $12.9 billion by 2019. It ... for the potential as well as established players in ... Asia-Pacific are positioned to witness growth at the highest ...
(Date:3/4/2015)... 2015 TheraBreath is proud to announce a ... could also help with overall health. , Many health ... help ward off bad bacteria that can cause unwanted infections. ... their own, most will need the help of a probiotic ... fighting levels. , Packed with the S. salivarius M18 & ...
Breaking Medicine News(10 mins):Health News:Increase in the Number of Nursing Mothers in the Workplace Spurs the Breast Pumps Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Increase in the Number of Nursing Mothers in the Workplace Spurs the Breast Pumps Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Brassica Protection Products Rebrands its SGS™ Brand of Glucoraphanin to truebroc™ 2Health News:Fifty Shades of Grey™ Has Canadians Talking About Sex. 2Health News:Defibrillators Market worth $12.9 Billion by 2019 with Rise in Aging Population - New Research Report by MarketsandMarkets 2Health News:Defibrillators Market worth $12.9 Billion by 2019 with Rise in Aging Population - New Research Report by MarketsandMarkets 3Health News:TheraBreath introduces a new line of probiotic lozenges that strengthen the body’s ability to fight germs 2
... , SAN FRANCISCO, July 23 The ... and transgender civil rights organization, today announced its speakers for ... 25, 2009, at the Westin St. Francis Hotel in San ... discuss issues impacting the LGBT community,s strive for human rights ...
... , , , ... announced that after laboratory analysis of electronic cigarette samples they have ... this does not ring true for U.S. based manufacturer, SmokeStik ... cartridges and listed several compounds of concern, such as, Diethylene Glycol, ...
... , WASHINGTON, July 23 The Community Oncology Alliance ... patients and community providers of cancer care, has responded in a ... , "We strongly support President Obama,s guiding ... fix what is broken., Unfortunately, that is the exact opposite of ...
... , WASHINGTON, July 23 The American ... president and CEO of Truman Medical Centers in Kansas City, Mo. ... 2011, becoming the top elected official of the national organization that ... , Bluford has been chief executive officer and ...
... , , , ... ALGN ) today reported financial results for the second quarter, ended June ... the second quarter of fiscal 2009 (Q2 09) were $76.3 million compared to $70.1 ... million reported in the second quarter of 2008 (Q2 08). Invisalign case shipments ...
... , SACRAMENTO, Calif., July 23 Oscar ... and Kipp Berdiansky, co-owner of the Psycho Donuts shop, participated in an ... host Rosy Chu. , , Oscar ... "As the former regional administrator of the U.S. Small Business Administration, ...
Cached Medicine News:Health News:Human Rights Campaign Announces Speakers at 25th Annual Bay Area Gala 2Health News:Human Rights Campaign Announces Speakers at 25th Annual Bay Area Gala 3Health News:RESPONSE to the FDA and Public Health Experts Findings on Electronic Cigarettes 2Health News:The Community Oncology Alliance Responds to President Obama's Press Conference Comments Regarding Cancer Patients 2Health News:The Community Oncology Alliance Responds to President Obama's Press Conference Comments Regarding Cancer Patients 3Health News:The Community Oncology Alliance Responds to President Obama's Press Conference Comments Regarding Cancer Patients 4Health News:AHA Board Elects John Bluford Chair-Elect Designate 2Health News:AHA Board Elects John Bluford Chair-Elect Designate 3Health News:Align Technology Announces Second Quarter Fiscal 2009 Results 2Health News:Align Technology Announces Second Quarter Fiscal 2009 Results 3Health News:Align Technology Announces Second Quarter Fiscal 2009 Results 4Health News:Align Technology Announces Second Quarter Fiscal 2009 Results 5Health News:Align Technology Announces Second Quarter Fiscal 2009 Results 6Health News:Align Technology Announces Second Quarter Fiscal 2009 Results 7Health News:Align Technology Announces Second Quarter Fiscal 2009 Results 8Health News:Align Technology Announces Second Quarter Fiscal 2009 Results 9Health News:Align Technology Announces Second Quarter Fiscal 2009 Results 10Health News:Align Technology Announces Second Quarter Fiscal 2009 Results 11Health News:Align Technology Announces Second Quarter Fiscal 2009 Results 12Health News:Align Technology Announces Second Quarter Fiscal 2009 Results 13Health News:Align Technology Announces Second Quarter Fiscal 2009 Results 14Health News:Mental Health Advocates Call for Psycho Donuts to Do the Right Thing 2
(Date:3/4/2015)... Mass. , March 4, 2015   HeartWare ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced that CEO Doug Godshall is ... Conference at 8:00 a.m. Eastern Time on Tuesday, March ... at the Loews Miami Beach Hotel in ...
(Date:3/4/2015)... Ga., March 4, 2015  Halyard Health, Inc. (NYSE: ... and provided its 2015 outlook and related key planning ... Halyard Health as we report our fourth quarter results, ... Chairman and CEO. "We executed a smooth separation from ... the spin-off. We delivered sales growth and margin improvement ...
(Date:3/4/2015)... March 4, 2015   InspireMD, Inc.  ("InspireMD" or ... protection systems ("EPS"), today announced that it has entered ... 34 million shares of common stock and warrants to ... stock in a public offering.  The common stock will ... per share, and each purchaser will receive a warrant ...
Breaking Medicine Technology:HeartWare Presentation At The 2015 Barclays Global Healthcare Conference To Be Webcast 2Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 2Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 3Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 4Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 5Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 6Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 7Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 8Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 9Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 10Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 11Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 12Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 13Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 14Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 15Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 16Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 17Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 18Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 19Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 20Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 21Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 22Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 23Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 24Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 25Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 26Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 27Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 28Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 29Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 30Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 31InspireMD Announces Public Offering for Approximately $13.5 Million 2InspireMD Announces Public Offering for Approximately $13.5 Million 3InspireMD Announces Public Offering for Approximately $13.5 Million 4
... April 7, 2008 Genta,Incorporated (Nasdaq: GNTA ... Injection, the Company,s lead anticancer,compound will be featured ... Cancer Research (AACR). The meeting will be held ... subject matter of several abstracts, which are,relevant to ...
... SAN FRANCISCO, April 4, 2008 VIA,Pharmaceuticals (Nasdaq: ... the,development of compounds for the treatment of cardiovascular ... Board (DSMB),for its VIA-2291 Phase 2 clinical trial ... current Phase 2 studies. The DSMB observed a,continued ...
Cached Medicine Technology:Specialized Genasense(R) Clinical Trials Featured at AACR Meeting 2Specialized Genasense(R) Clinical Trials Featured at AACR Meeting 3VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 2VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 3VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 4
This 1000 L tip is the equivalent to the "Blue" tips and fits nearly every manufacturer's 1000 L pipettor....
Conducting disposable filter-tips....
Designed to fit a variety of 250 L and 300 ul multi-channel pipettors, this tip offers a secure fit and extra space for repeat pipetting....
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio...
Medicine Products: